- Home
- COGT vs BIT Comparison
COGT vs BIT Comparison
Compare COGT & BIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- BIT
- Stock Information
- Founded
- COGT 2014
- BIT 2013
- Country
- COGT United States
- BIT United States
- Employees
- COGT N/A
- BIT N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- BIT Trusts Except Educational Religious and Charitable
- Sector
- COGT Health Care
- BIT Finance
- Exchange
- COGT Nasdaq
- BIT Nasdaq
- Market Cap
- COGT 555.6M
- BIT 599.5M
- IPO Year
- COGT 2018
- BIT N/A
- Fundamental
- Price
- COGT $5.44
- BIT $14.23
- Analyst Decision
- COGT Buy
- BIT
- Analyst Count
- COGT 6
- BIT 0
- Target Price
- COGT $15.20
- BIT N/A
- AVG Volume (30 Days)
- COGT 1.2M
- BIT 92.4K
- Earning Date
- COGT 05-06-2025
- BIT 01-01-0001
- Dividend Yield
- COGT N/A
- BIT 9.36%
- EPS Growth
- COGT N/A
- BIT N/A
- EPS
- COGT N/A
- BIT N/A
- Revenue
- COGT N/A
- BIT N/A
- Revenue This Year
- COGT N/A
- BIT N/A
- Revenue Next Year
- COGT N/A
- BIT N/A
- P/E Ratio
- COGT N/A
- BIT N/A
- Revenue Growth
- COGT N/A
- BIT N/A
- 52 Week Low
- COGT $3.72
- BIT $13.65
- 52 Week High
- COGT $12.61
- BIT $15.97
- Technical
- Relative Strength Index (RSI)
- COGT 56.27
- BIT 52.08
- Support Level
- COGT $4.80
- BIT $14.07
- Resistance Level
- COGT $4.99
- BIT $14.37
- Average True Range (ATR)
- COGT 0.31
- BIT 0.12
- MACD
- COGT 0.07
- BIT -0.02
- Stochastic Oscillator
- COGT 88.56
- BIT 32.65
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About BIT BlackRock Multi-Sector Income Trust of Beneficial Interest
BlackRock Multi-Sector Income Trust is a closed-end investment management company. It invests on behalf of its clients. The fund's primary investment objective is to provide a high level of current income, with a secondary objective of capital appreciation. The company seeks to achieve its investment objectives by investing, under normal market conditions, a majority of its assets in loan and debt instruments and other investments with similar economic characteristics. Its portfolio consists of Corporate Bonds, Asset-Backed Securities, Preferred Securities, and others.